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(67%) had a minor infarct (25% of cortex), 9 (16%)
moderate (25-50% of cortex), and 2 (4%) severe (50%
of cortex). All but one patient were treated nonopera-
tively, using anticoagulation in 36 patients (86%) for a
mean duration of 5.7 months (range 1-24), life-long
aspirin therapy in 29 (69%), and blood pressure control
in 35 (83%). An attempt at ex-vivo repair in the operative
patient failed. Thirty-four patients (81%) developed new
onset of HTN within 1 year and were on 1.1 (range, 0-3)
antihypertensive medications at 1 year. Three patients
(7%) had a recurrent dissection, 41 (98%) had a normal
creatinine, and no patient died or required dialysis over a
mean follow-up of 35 months (range 0-279).
Conclusions: Nonoperative management of ISDRA is
feasible and safe in most patients.
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ling Pathway
Hemanshu Patel1, George Hamilton1, David Abraham1,
Daryll Baker1, Sidney Shaw2, Janice Tsui1. 1Division of
Surgery & Interventional Science, UCL, London, United
Kingdom; 2University of Bern, Bern, Switzerland
Objectives: Critical limb ischemia is associated with
skeletal muscle damage and tissue loss, however its patho-
physiology is poorly understood. Toll-like receptors
(TLRs) have been implicated in iscaemia-induced tissue
damage. TLR 2 & 6 in particular have been implicated in
critically ischemic muscle. Two separate signalling path-
ways exist for the signalling transduction of TLRs: the
MyD88-dependent pathway and the MyD88-independen
pathway. We aim to investigate which TLR signalling path-
ways are involved in ischemia-induced muscle damage. We
hypothesize that skeletal muscle ischemia induces TLR 2&
6 heterodimerisation and activation of the MyD88 depen-
dent pathway resulting in cytokine-mediated muscle
damage.
Methods: TLR 2 and 6 expression in ischemic and
control human muscle biopsies and in C2C12 myotubes
cultured in ischemic conditions were studied usingWestern
blot and immunohistochemistry. TLR 2& 6 heterodimeri-
sation was confirmed by co-immunoprecipitation. Func-
tional effects of TLR 2/6 and MyD88 antagonism on
ischemia-induced IL-6 release and apoptosis were studied
with neutralizing TLR 2/6 antibodies and aMyD88 inhib-
itor. IL-6 release was assayed by ELISA and apoptosis was
assessed using cleaved caspase-3.
Results: TLR 2 and 6 protein expression was signif-
icantly upregulated in ischemic muscle and ischemic
C2C12 myotubes (P.05). TLR 2 and 6 heterodimerise
under ischemic conditions with consequent activation of
the signaling pathway. Ischemia-induced IL-6 produc-
tion and apoptosis were reduced by TLR 2/6 antago-
nism and MyD88 inhibition.
Conclusions:Upregulation of TLR 2 and 6 expression
occurs in CLI. Heterodimerisation of TLR 2 and TLR 6
and the subsequent activation of the signaling pathway
results in IL-6 release and apoptosis which contributes to
inflammation and muscle damage in ischemia. Further we
have provided novel evidence that the MyD88 dependent
pathway is critical in the signalling process and maybe a
potential therapeutic target.
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Objectives: Despite advancements in renal replace-
ment therapy, mortality with acute kidney injury(AKI)
remains high, likely due to remote organ injury. Kidney
ischemia-reperfusion injury(IRI) activates cellular and soluble
mediators, driving lung inflammation, TNFR1-mediated ap-
optosis and microvascular barrier dysfunction. We hypothe-
sized that lung microvascular endothelial cells(ECs), with
their integral role maintaining the lung semipermeable bar-
rier, were key cellular targets of TNFR1-mediated apoptosis
during ischemic AKI.
Methods: Male C57/BL6 mice and Sprague-Dawley
rats underwent 60min bilateral renal pedicle occlusion(IRI)
or sham laparotomy(sham) and sacrifice at 4 or 24hrs.
TUNEL/DAPI/CD34 colocalization identified EC apo-
ptosis in vivo and ECs[CD45-/CD31] isolated by novel
techniques underwent RT-PCR Apoptosis SuperArray
analysis. In parallel, rat lung microvascular ECs(RLM-
VECs) treated with serum from rats after sham or IRI
underwent custom RT-PCR analysis for apoptosis and
TNF family gene transcription; capase-3 and PARP activity
assays identified RLMVEC apoptosis. Separately, inflam-
matory genes and apoptosis were compared in RLMVECs
treated with TNF/TNFR1 signaling inhibition (Etaner-
cept vs vehicle) during ischemic AKI.
Results: In vivo, TUNEL cells colocalized with
CD34 during ischemic AKI and isolated lung ECs demon-
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